Inquire Before Buying - Type-2 Diabetes Market grow at a CAGR of around 5.39% By 2030

Global Type-2 Diabetes Market Research Report: Forecast (2025-2030)

Type-2 Diabetes Market - By Drug Type (Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Alpha-glucosidase Inhibitors, Biguanides, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, Sodiu......m-Glucose Cotransporter 2 Inhibitors (SGLT2), Sulfonylureas, Other (Thiazolidinediones, Meglitinides, Glitazones, etc.), By Gender Type (Male, Female), By Age Group (Upto 19 Years, 20 – 65 Year, Above 65), By Region (North America, South America, Europe, Middle East & Africa, Asia-Pacific), By Country (U.S., Canada, Mexico, Brazil, Argentina, U.K., Germany, France, Italy, Spain, UAE, Saudi Arabia, South Africa, China, India, Japan, South Korea, Australia, South East Asia), By Comany (Merck & Co, AstraZeneca, Novo Nordisk, Bristol-Myers Squibb, Eli Lilly, Sanofi, Boehringer Ingelheim, Pfizer, Takeda, Biocon, Johnson & Johnson), and others. Read more

Healthcare
May 2025
Pages 178
Report Format: PDF, Excel, PPT

Market Definition

Diabetes is a chronic metabolic disease marked by elevated levels of blood glucose (or blood sugar) that results in severe damage to the kidneys, heart, blood vessels, eyes, and nerves over time. Broadly, there are two types of diabetes, Type-1, and Type-2. Type 2 diabetes, usually common in adults, occurs when the body doesn't make enough insulin or becomes resistant to it.

Market Insights & Analysis: Global Type-2 Diabetes Market (2025-30):

The Global Type-2 Diabetes Market size was valued at around USD 52.7 billion in 2024 and is expected to reach USD 72.21 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 5.39% during the forecast period, i.e., 2025-30.

The market growth is favorably fostered by the increasing prevalence of type 2 diabetes stemming from unhealthy lifestyles, physical inactivity, and obesity. According to WHO, around 422 million people worldwide have diabetes, out of which the majority live in low-and middle-income countries. In addition, diabetes accounts for more than 1.5 million deaths each year. The number of cases and the prevalence of diabetes have witnessed expansion over the past few decades. In addition, the rising geriatric population, along with the surging population with type-1 diabetes and the lack of proper healthcare infrastructure in emerging countries, are projected to boost the growth of the type-2 Diabetes market globally in the forthcoming years.

Report Coverage	Details
Historical Years	2020–23
Base Years	2024
Forecast Years	2025–30
Market Value in 2024	USD 52.7 Billion
Market Value by 2030	USD 72.21 Billion
CAGR (2025–30)	5.39%
Leading Region	North America
Top Key Players	Merck & Co, AstraZeneca, Novo Nordisk. Bristol-Myers Squibb, Eli Lilly, Sanofi, Boehringer Ingelheim, Pfizer, Takeda, Biocon, Johnson & Johnson, and others
Segmentation	By Drug Type (Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Alpha-glucosidase Inhibitors, Biguanides, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2), Sulfonylureas, Other (Thiazolidinediones, Meglitinides, Glitazones, etc.), By Gender Type (Male, Female), By Age Group (Upto 19 Years, 20 – 65 Year, Above 65), By Region (North America, South America, Europe, Middle East & Africa, Asia-Pacific), By Country (U.S., Canada, Mexico, Brazil, Argentina, U.K., Germany, France, Italy, Spain, UAE, Saudi Arabia, South Africa, China, India, Japan, South Korea, Australia, South East Asia), By Comany (Merck & Co, AstraZeneca, Novo Nordisk, Bristol-Myers Squibb, Eli Lilly, Sanofi, Boehringer Ingelheim, Pfizer, Takeda, Biocon, Johnson & Johnson), and others.
Key Report Highlights	Market Dimensions & Projections Pricing Evaluation Recent Strategic Moves by Companies Primary Stakeholders Import/Export Trend Analysis Competitive Landscape Assessment Emerging Opportunities Market Trends and Indicators

*Boost strategic growth with in-depth market analysis - Get a free sample preview today!

Key players such as AstraZeneca, Pfizer, Johnson & Johnson, etc., bring forth innovative medical devices to aid diabetic patients. Besides, to gain a competitive edge over the other market players and have a strong foothold worldwide, these companies are collaborating with other pharmaceutical firms to launch products in other markets. Moreover, to make the diabetes digital health space less congested, the companies have entered the digital market by launching mobile health apps for the customer to ease them by constantly tracking their type 2 diabetes regimes. These aspects are likely to accentuate the market expansion in the coming years.

Introduction
1. Research Process
2. Market Segmentation
3. Market Definition
4. Assumptions
Executive Summary
Expert Verbatim
Impact of Covid-19
1. Short Term Impact
2. Long Term Impact
Global Type 2 Diabetes Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. Market Revenues
2. Market Share & Analysis
  1. By Drug Type
    1. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
    2. Alpha-glucosidase Inhibitors
    3. Biguanides
    4. Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists
    5. Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2)
    6. Sulfonylureas
    7. Other (Thiazolidinediones, Meglitinides, Glitazones, etc.)
  2. By Gender
    1. Male
    2. Female
  3. By Age Group
    1. Upto 19 years
    2. 20 – 65 years
    3. Above 65 years
  4. By Region
    1. North America
    2. South America
    3. Europe
    4. Middle East & Africa
    5. Asia-Pacific
  5. By Company
    1. Revenue Shares
    2. Strategic Factorial Indexing
    3. Competitor Placement in MarkNtel Quadrant
3. Market Attractiveness Index
  1. By Drug Type
  2. By Gender
  3. By Age Group
  4. By Region
North America Type 2 Diabetes Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. Market Revenues
2. Market Share & Analysis
  1. By Drug Type
  2. By Gender
  3. By Age Group
  4. By Country
    1. The US
    2. Canada
    3. Mexico
3. Market Attractiveness Index
  1. By Drug Type
  2. By Gender
  3. By Age Group
  4. By Country
4. The US Type 2 Diabetes Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues
  2. Market Share & Analysis
    1. By Drug Type
5. Canada Type 2 Diabetes Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues
  2. Market Share & Analysis
    1. By Drug Type
6. Mexico Type 2 Diabetes Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues
  2. Market Share & Analysis
    1. By Drug Type
7. Competitive Scenario for various Countries
  1. Mapping Countries and Market Potential (High, Medium, Low)
  2. Companies Dominating in Countries
South America Type 2 Diabetes Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. Market Revenues
2. Market Share & Analysis
  1. By Drug Type
  2. By Gender
  3. By Age Group
  4. By Country
    1. Brazil
    2. Argentina
    3. Others
3. Market Attractiveness Index
  1. By Drug Type
  2. By Gender
  3. By Age Group
  4. By Country
4. Brazil Type 2 Diabetes Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues
  2. Market Share & Analysis
    1. By Drug Type
5. Argentina Type 2 Diabetes Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues
  2. Market Share & Analysis
    1. By Drug Type
6. Competitive Scenario for various Countries
  1. Mapping Countries and Market Potential (High, Medium, Low)
  2. Companies Dominating in Countries
Europe Type 2 Diabetes Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. Market Revenues
2. Market Share & Analysis
  1. By Drug Type
  2. By Gender
  3. By Age Group
  4. By Country
    1. The UK
    2. Germany
    3. France
    4. Italy
    5. Spain
    6. Others
3. Market Attractiveness Index
  1. By Drug Type
  2. By Gender
  3. By Age Group
  4. By Country
4. The UK Type 2 Diabetes Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues
  2. Market Share & Analysis
    1. By Drug Type
5. Germany Type 2 Diabetes Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues
  2. Market Share & Analysis
    1. By Drug Type
6. France Type 2 Diabetes Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues
  2. Market Share & Analysis
    1. By Drug Type
7. Italy Type 2 Diabetes Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues
  2. Market Share & Analysis
    1. By Drug Type
8. Spain Type 2 Diabetes Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues
  2. Market Share & Analysis
    1. By Drug Type
9. Competitive Scenario for various Countries
  1. Mapping Countries and Market Potential (High, Medium, Low)
  2. Companies Dominating in Countries
Middle East & Africa Type 2 Diabetes Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. Market Revenues
2. Market Share & Analysis
  1. By Drug Type
  2. By Gender
  3. By Age Group
  4. By Country
    1. UAE
    2. Saudi Arabia
    3. South Africa
    4. Others
3. Market Attractiveness Index
  1. By Drug Type
  2. By Gender
  3. By Age Group
  4. By Country
4. UAE Type 2 Diabetes Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues
  2. Market Share & Analysis
    1. By Drug Type
5. Saudi Arabia Type 2 Diabetes Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues
  2. Market Share & Analysis
    1. By Drug Type
6. South Africa Type 2 Diabetes Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues
  2. Market Share & Analysis
    1. By Drug Type
7. Competitive Scenario for various Countries
  1. Mapping Countries and Market Potential (High, Medium, Low)
  2. Companies Dominating in Countries
Asia-Pacific Type 2 Diabetes Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. Market Revenues
2. Market Share & Analysis
  1. By Drug Type
  2. By Gender
  3. By Age Group
  4. By Country
    1. China
    2. India
    3. Japan
    4. South Korea
    5. Australia
    6. South East Asia
    7. Others
3. Market Attractiveness Index
  1. By Drug Type
  2. By Gender
  3. By Age Group
  4. By Country
4. China Type 2 Diabetes Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues
  2. Market Share & Analysis
    1. By Drug Type
5. India Type 2 Diabetes Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues
  2. Market Share & Analysis
    1. By Drug Type
6. Japan Type 2 Diabetes Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues
  2. Market Share & Analysis
    1. By Drug Type
7. South Korea Type 2 Diabetes Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues
  2. Market Share & Analysis
    1. By Drug Type
8. Australia Type 2 Diabetes Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues
  2. Market Share & Analysis
    1. By Drug Type
9. South East Asia Type 2 Diabetes Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues
  2. Market Share & Analysis
    1. By Drug Type
10. Competitive Scenario for various Countries
  1. Mapping Countries and Market Potential (High, Medium, Low)
  2. Companies Dominating in Countries
Global Type 2 Diabetes Regulations, Product Standards
Global Type 2 Diabetes Value Chain Analysis
Consumer Behavior Analysis
1. Consumer Trends and Preferences
2. Factors Affecting Buying Decision
Global Type 2 Diabetes Market Dynamics
1. Drivers
2. Challenges
3. Impact Analysis
Global Type 2 Diabetes Market Hotspots & Opportunities
Global Type 2 Diabetes Market Trends & Insights
Global Type 2 Diabetes Price Analysis
Global Type 2 Diabetes Market Key Strategic Imperatives for Success & Growth
Competition Outlook
1. Competitor Wise Growth Strategies
  1. Product Portfolio
  2. Target Market
  3. Target Age Group
  4. Manufacturing Units
  5. Research & Development
  6. Strategic Alliances & Initiatives
2. Company Profiles of top companies (Business Description, Product Segments, Business Segments, Financials, Strategic Alliances/ Partnerships, Future Plans)
  1. Merck & Co
  2. AstraZeneca
  3. Novo Nordisk
  4. Bristol-Myers Squibb
  5. Eli Lilly
  6. Sanofi
  7. Boehringer Ingelheim
  8. Pfizer
  9. Takeda
  10. Biocon
  11. Johnson & Johnson
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

FILL THE FORM TO INQUIRE BEFORE BUYING THIS REPORT

Name *

Email ID *

Country *